GRDX
GridAI Technologies Corp.
NASDAQ · Healthcare · Biotechnology · US
$4.39
+4.03%Year over year
Reported trailing growth
- Revenue
- +67.4%
- EBITDA
- —
- EBIT
- —
- EPS
- -17.4%
- Free cash flow
- —
- Operating cash flow
- —
Forward estimates
Based on analyst estimates
- Revenue
- +114.2%
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- —
- EBITDA
- +58.2%
- EBIT
- +54.7%
- Net income
- +64.6%
- EPS
- +22.0%
- Free cash flow
- +38.1%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026